StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) Set to Open Lower Following Downgrade
December 2, 2019 6:51 AM
Biogen (NASDAQ: BIIB) traded ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Biogen (BIIB) Reports Positive Phase 2 Study Results for Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE)
December 3, 2019 7:32 AM
Biogen (BIIB) option implied volatility bid into Alzheimer’s treatment data
December 2, 2019 5:33 AM
Baird Downgrades Biogen (BIIB) to Underperform on Alzheimer's Hype, 'CTAP Looks Ripe for Downside'
December 2, 2019 4:30 AM